- Most therapeutic peptides in Australia are Schedule 4 (prescription only) under the TGA Poisons Standard; some are Schedule 9 (prohibited)
- The fitness-related peptide market in Australia largely operates outside the legal framework: most products sold online are unapproved, unregulated, and carry no quality assurance
- Competitive athletes face additional risk: many peptides are banned under the WADA Prohibited List and ASADA's framework, with improving detection methods
- Peptides can affect the liver, kidneys, lipid profile, and hormonal axis; these effects are invisible without blood testing
- If you are using peptides, a baseline blood panel and periodic monitoring are the most practical harm-reduction steps available
What are peptides?
Peptides are short chains of amino acids: the same building blocks that make up proteins, but in smaller sequences typically between two and fifty amino acids long. Because of their size and structure, peptides act as signalling molecules in the body, binding to receptors and triggering specific biological responses.
The category is broad. Peptides include naturally occurring hormones such as insulin and oxytocin, as well as synthetic compounds designed to mimic or amplify those signals. The peptides circulating in Australian fitness and wellness communities tend to fall into a few functional categories:
- Growth hormone secretagogues (CJC-1295, ipamorelin, GHRP-2, GHRP-6): stimulate the pituitary gland to release growth hormone
- Tissue repair peptides (BPC-157, TB-500/thymosin beta-4): associated with accelerated healing of tendons, ligaments, and soft tissue in animal studies
- Tanning and body composition peptides (Melanotan II, PT-141): act on melanocortin receptors
- Nootropic and mood peptides (selank, semax): claimed to affect cognition and stress response
The wide range of claimed effects, combined with a relatively accessible market, has made peptides popular among athletes, gym-goers, and biohackers across Australia.
The legal framework: what the TGA actually says
Australia's therapeutic goods are regulated by the Therapeutic Goods Administration under the Therapeutic Goods Act 1989. Medicines and substances are classified into schedules under the Poisons Standard, which determines how they can be supplied.[1]
The two schedules most relevant to peptides are:
Schedule 4: Prescription Only Medicines. Substances in Schedule 4 can only be legally supplied to a patient with a valid prescription from an authorised prescriber. A pharmacist cannot dispense them without one; a gym or supplement retailer cannot sell them at all.
Schedule 9: Prohibited Substances. Schedule 9 is reserved for substances with a high potential for abuse or no accepted therapeutic use in Australia. Supply of Schedule 9 substances is restricted to approved research purposes only.
Most therapeutic peptides used in fitness contexts sit in Schedule 4. Following a review by the TGA's scheduling delegate in 2023, several peptides had their scheduling confirmed or tightened, and the legal status of unapproved peptide products sold as "research chemicals" was clarified: they remain subject to scheduling provisions regardless of how they are labelled.[5]
The "research chemical" label does not create a legal exemption. Many online peptide suppliers label products as "not for human consumption" or "research use only." Under Australian law, the scheduling of a substance is determined by its chemical composition and intended use, not by a label. A Schedule 4 substance sold as a research chemical is still a Schedule 4 substance. The TGA has taken action against suppliers using this framing.
Can a doctor prescribe peptides?
Yes, in specific circumstances. The TGA provides pathways for patients to legally access unapproved therapeutic goods.[2]
The Special Access Scheme (SAS): Allows registered medical practitioners to apply for TGA approval to prescribe an unapproved medicine for an individual patient with a specific medical condition. SAS Category B applications require a specific justification and TGA approval before supply.
Authorised Prescriber pathway: A medical practitioner can apply to become an authorised prescriber for a specific unapproved medicine in a specific indication, allowing them to prescribe it to patients without applying for SAS approval each time.
In practice, access to peptides through these pathways is limited to patients with a genuine clinical need and a practitioner willing to pursue the application. Compounding pharmacies may be able to prepare certain peptide formulations under this framework.
For most fitness and performance applications, no approved indication exists and no pathway is available. This is a meaningful distinction between peptides and, say, a low-dose testosterone prescription, which does have approved indications and a clear prescribing pathway.
Athletes: the ASADA and WADA layer
For competitive athletes, there is an additional and separate regulatory framework. The World Anti-Doping Agency publishes an annual Prohibited List that bans specific substances and classes of substances in sport.[4] The Australian Sports Anti-Doping Authority (ASADA) administers these rules for Australian athletes and sports organisations.[3]
Peptides appear in several categories of the Prohibited List:
- S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics. This class includes growth hormone and its secretagogues (the CJC/ipamorelin/GHRP family), IGF-1, and a broad range of growth factors.
- S0: Non-Approved Substances. This catch-all category prohibits any pharmacological substance not approved for human therapeutic use. Many peptides sold in the grey market fall here.
Anti-doping detection methods for peptides have improved substantially over the past decade. Athletes in ASADA-registered sports should treat any substance on the Prohibited List as a career risk, regardless of whether it is "natural" or widely used in their training environment.
What does this mean in practice?
Honestly: a significant gap exists between the legal framework and how peptides are actually used in Australian gym and sports communities.
Grey-market peptide products are widely available online. They are shipped into Australia from overseas manufacturers, sold with minimal regulatory oversight, and used routinely by people who may not be aware of the legal status, the quality risks, or the physiological effects on organ systems.
This does not mean the risks disappear because use is widespread. It means they are largely invisible, because people using grey-market products rarely get blood work done to see what those products are actually doing to their bodies.
Why blood monitoring matters
Peptides are not inert. The most commonly used fitness peptides affect real physiological systems, and those effects can be tracked, and caught early, with standard blood tests.
Growth hormone secretagogues and IGF-1
CJC-1295, ipamorelin, and the GHRP variants all work by stimulating growth hormone release. Elevated growth hormone increases hepatic IGF-1 production. Chronically elevated IGF-1 is associated with increased insulin resistance, and at high levels with changes in soft tissue, glucose handling, and cardiovascular risk markers. Standard tests: IGF-1, fasting glucose, HbA1c, fasting lipids.
Liver function
Any substance taken by injection or at pharmacological doses places a load on hepatic processing. Growth hormone and its secretagogues are associated with transient increases in liver enzymes in some individuals. Standard tests: ALT, AST, GGT, ALP, bilirubin (full LFT panel).
Kidney function
The kidneys filter waste products of protein and peptide metabolism. In people already training hard and consuming high protein, the addition of pharmacological peptides warrants baseline and periodic kidney function assessment. Standard tests: eGFR, creatinine, urea (UEC panel).
Hormonal axis
Growth hormone secretagogues can suppress the natural pulsatile GH rhythm if used chronically, and some users report downstream effects on testosterone and cortisol. Melanotan II affects the HPA axis. Tracking a baseline hormone panel allows you to detect changes that are clinically meaningful before they become symptomatic. Standard tests: testosterone (total and free), LH, FSH, cortisol, thyroid function.
Lipid profile
Growth hormone has direct effects on lipid metabolism: acute increases in GH tend to raise free fatty acids, and long-term GH effects on lipids are complex and dose-dependent. A fasting lipid panel is cheap and provides a useful baseline. Standard tests: total cholesterol, LDL, HDL, triglycerides.
The gap between "I feel fine" and "my bloods look fine" can be significant. Many of the changes associated with peptide use are subclinical in the early stages: a mild rise in liver enzymes, a shift in the testosterone:LH ratio, borderline IGF-1. These do not produce symptoms that would lead someone to seek medical attention, but they are visible on a blood panel and provide information you can act on.
What to test and when
If you are using or considering using peptides, a practical monitoring approach:
Baseline (before starting): Full blood count, liver function (LFT), kidney function (UEC), fasting lipids, testosterone and LH (males), IGF-1, thyroid function (TFT), hs-CRP.
Follow-up (8 to 12 weeks after starting): Repeat LFT, testosterone, IGF-1. Compare to baseline.
Annual review: Full repeat of the baseline panel.
This is not a clinical protocol endorsed by any health body; it is a practical framework for harm reduction in a context where most GP visits do not include a conversation about peptide use. Having a documented baseline is valuable precisely because it gives you a reference point if something changes.
A note on quality
Grey-market peptide products vary widely in actual content, purity, and concentration. Studies testing commercially available peptide products have found significant discrepancies between labelled and actual content, contamination with unrelated substances, and sterility issues in injectable products. This is a separate category of risk from the physiological effects of the peptides themselves.
If you are seeking medically supervised access, the SAS and compounding pharmacy pathway, while limited in scope, does provide products prepared under pharmaceutical standards, which is meaningfully different from an overseas-sourced vial with a printed label.
FAQ
Can I buy peptides over the counter in Australia?
No. Most therapeutic peptides are Schedule 4 (prescription only) under the Poisons Standard. Purchasing without a valid prescription from a registered supplier is unlawful.
Can a doctor legally prescribe peptides in Australia?
Yes, but only where an approved registered product exists or via the TGA's Special Access Scheme for unapproved medicines. Many commonly used fitness-related peptides have no approved indication and would require SAS approval, which is granted on a case-by-case basis.
Will peptide use show up in a drug test for sport?
Many peptides are banned under the WADA Prohibited List and ASADA's framework. This includes peptide hormones, growth factors, and substances in the S0 non-approved category. Detection methods have improved significantly in recent years. Competitive athletes should check the ASADA Prohibited List before using any substance.
Do peptides affect testosterone?
Growth hormone secretagogue peptides can indirectly influence testosterone dynamics via the HPG axis. Some users report changes in LH and testosterone levels with prolonged use. A hormone panel provides a baseline and allows you to detect changes.
What blood tests should I ask for if I am using peptides?
A sensible monitoring panel covers: full blood count, liver function (LFT), kidney function (UEC), fasting lipids, testosterone and LH, IGF-1, and hs-CRP. This covers the key organ systems most likely to be affected by commonly used performance peptides.
